TITLE

MINI-CHROMOSOME MAINTENANCE PROTEINS PROVIDE A NOVEL METHOD FOR DETECTING PATIENTS AT RISK OF DEVELOPING ADENOCARCINOMA IN BARRETT'S OESOPHAGUS

AUTHOR(S)
Sirieix, P.S.; O'Donovan, M.; Brown, J.; Coleman, N.; Fitzgerald, R.C.
PUB. DATE
April 2003
SOURCE
Gut;Apr2003 Supplement 1, Vol. 52, pA46
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Introduction: Oesophageal adenocarcinoma incidence is increasing rapidly. Endoscopic screening for the population at risk is not feasible and surveillance of patients with known Barrett's oesophagus (BE) is prone to sampling bias and the subjective interpretation of dysplasia. Aims: To determine whether a novel marker of cell cycle entry, mini-chromosome maintenance (MCM) protein predicted cancer risk and whether this could be used in combination with a surface sampling method. Methods: Archival specimens (30 squamous oesophagus (SE), 62 BE +/- dysplasia, 16 adenocarcinoma (AC)) were stained for Mcm2. In addition, 9 patients with 3-13 years follow up who developed AC were compared with 18 controls matched for age and length of follow up who did not progress. Endoscopic cytological brushings were taken from a prospective cohort (61 SE, 90 BE +/- dysplasia and 11 AC) and scored blind as Mcm2 positive or negative. Results: Correlation between Mcm2 surface expression and dysplasia (p<0.05 for biopsies and brushings). Since ∼40% of non-dysplastic BE samples were Mcm2 positive we tested whether surface expression predicted progression. 13/14 (93%) cancer patient biopsies, prior to any dysplasia diagnosis, were Mcm2 positive on the surface compared with 13/67 (19%) biopsies from matched controls. Conclusion: Surface expression of Mcm2 can be used to detect the population at risk of developing high grade dysplasia and AC. A combined brushing technique with Mcm staining has the potential to be exploited as a non-endoscopic screening test.
ACCESSION #
9747576

 

Related Articles

  • Characterisation of p53 status at the gene, chromosomal and protein levels in oesophageal adenocarcinoma. Doak, S.H.; Jenkins, G.J.S.; Parry, E.M.; Griffiths, A.P.; Shah, V.; Baxter, J.N.; Parry, J.M. // British Journal of Cancer;11/3/2003, Vol. 89 Issue 9, p1729 

    p53 mutations and loss of heterozygosity have been commonly associated with oesophageal adenocarcinoma. In this investigation, the p53 status of a Welsh population of Barrett's-associated oesophageal adenocarcinomas were fully characterised at the gene sequence, chromosomal, mRNA and protein...

  • A common p73 polymorphism is associated with a reduced incidence of oesophageal carcinoma. Ryan, B M; McManus, R; Daly, J S; Carton, E; Keeling, P W N; Reynolds, J V; Kelleher, D // British Journal of Cancer;11/15/2001, Vol. 85 Issue 10, p1499 

    The incidence of oesophageal adenocarcinoma is rising; to date, no susceptibility genes have been identified. p73, a novel p53 homologue, maps to chromosome 1p36, a region commonly deleted in oesophageal cancers. p73 shares some p53-like activity, but in addition, may also play a role in...

  • Novel 5-fluorouracil-resistant human esophageal squamous cell carcinoma cells with dihydropyrimidine dehydrogenase overexpression. Osamu Kikuchi; Shinya Ohashi; Yukie Nakai; Shunsaku Nakagawa; Kazuaki Matsuoka; Takashi Kobunai; Teiji Takechi; Yusuke Amanuma; Masahiro Yoshioka; Tomomi Ida; Yoshihiro Yamamoto; Yasushi Okuno; Shin'ichi Miyamoto; Hiroshi Nakagawa; Kazuo Matsubara; Tsutomu Chiba; Manabu Muto // American Journal of Cancer Research;2015, Vol. 5 Issue 8, p2431 

    5-Fluorouracil (5-FU) is a key drug for the treatment of esophageal squamous cell carcinoma (ESCC); however, resistance to it remains a critical limitation to its clinical use. To clarify the mechanisms of 5-FU resistance of ESCC, we originally established 5-FU-resistant ESCC cells, TE-5R, by...

  • CXCR4 expression as a predictive biomarker for esophageal cancer. Yanmei Ma; Jianxiang Zhang; Jinping Zhang // International Journal of Clinical & Experimental Medicine;2016, Vol. 9 Issue 11, p22055 

    Background: The CXC chemokine receptor type 4 (CXCR4) has been linked to tumor growth, dissemination and local immune in many malignancies. However, the clinicopathological and prognostic significance of CXCR4 for survival of patients with esophageal cancer is still controversial. The aim of our...

  • Characterization of a 500 kb region on 17q25 and the exclusion of candidate genes as the familial Tylosis Oesophageal Cancer (TOC) locus. Risk, Janet M.; Evans, Kathryn E.; Jones, Joanne; Langan, Joanne E.; Rowbottom, Lyn; McRonald, Fiona E.; Mills, Helen S,; Ellis, Anthony; Shaw, Joan M; Leigh, Irene M.; Kelsell, David P.; Field, John K. // Oncogene;9/12/2002, Vol. 21 Issue 41, p6395 

    Presents a study which mapped the locus for a syndrome of focal palmoplantar keratoderma associated with squamous cell esophageal cancer in chromosome 17q25, a region frequently deleted in sporadic squamous cell esophageal tumors. Exclusion of candidate genes as the familial Tylosis esophageal...

  • A new mixture model approach to analyzing allelic-loss data using Bayes factors. Desai, Manisha; Emond, Mary J. // BMC Bioinformatics;2004, Vol. 5, p182 

    Background: Allelic-loss studies record data on the loss of genetic material in tumor tissue relative to normal tissue at various loci along the genome. As the deletion of a tumor suppressor gene can lead to tumor development, one objective of these studies is to determine which, if any,...

  • Metastasis-Associated Protein 1 (MTA1) Overexpression is Closely Associated with Shorter Disease-Free Interval After Complete Resection of Histologically Node-Negative Esophageal Cancer. Shu-Hai Li; Zhou Wang; Xiang-Yan Liu // World Journal of Surgery;Sep2009, Vol. 33 Issue 9, p1876 

    The purpose of the present study was to investigate the expression of metastasis-associated protein 1 (MTA1) and its relationship to the disease-free interval after resection of pathologic N0 (pN0) esophageal squamous cell cancer (ESCC). The subjects were 90 patients who successfully underwent...

  • Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma. Uchida, S; Shimada, Y; Watanabe, G; Li, Z Gang; Hong, T; Miyake, M; Imamura, M // British Journal of Cancer;3/1/99, Vol. 79 Issue 7/8, p1168 

    Although the mechanisms of action of the transmembrane superfamilies, motility-related protein-1 (MRP-1/CD9) and KAI1/CD82, are not well known, they are reported to suppress the metastasis of several kinds of cancers. The suppression of cell motility by MRP-1/CD9 may cause suppression of the...

  • An Obstructing Large Schwannoma in the Esophagus. Ho Young Yoon; Choong Bai Kim; Yoon Hee Lee; Ho Geun Kim // Journal of Gastrointestinal Surgery;Apr2008, Vol. 12 Issue 4, p761 

    Esophageal schwannoma is very rare neoplasm, which is difficult to diagnose by endoscopy or radiologic evaluations. The diagnosis is not confirmed until immunohistochemical tests are performed after a surgeon has resected the lesion. We present the case of a 65-year-old male patient with an...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics